AsperSAN (sanPharma GmbH)
Welcome to the PulseAid listing for the AsperSAN drug offered from sanPharma GmbH. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | sanPharma GmbH |
NON-PROPRIETARY NAME: | ASPERGILLUS NIGER VAR. NIGER |
SUBSTANCE NAME: | ASPERGILLUS NIGER VAR. NIGER |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2017-01-04 |
END MARKETING DATE: | 0000-00-00 |
AsperSAN HUMAN OTC DRUG Details:
Item Description | AsperSAN from sanPharma GmbH |
LABELER NAME: | sanPharma GmbH |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4([hp_X]/10mL) |
START MARKETING DATE: | 2017-01-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 64232-030_3e14d034-a735-411f-a749-00f1f5437b5d |
PRODUCT NDC: | 64232-030 |
APPLICATION NUMBER: | |
Other ASPERGILLUS NIGER VAR. NIGER Pharmaceutical Manufacturers / Labelers: